Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Cheung, Carol Yim-luia; b; c; 1; * | Ong, Yi Tinga; b; d; 1 | Hilal, Saimab; e; h | Ikram, M. Kamrana; b; c; e | Low, Sallya | Ong, Yi Lina | Venketasubramanian, N.e | Yap, Philipf | Seow, Dennisg | Chen, Christopher Li Hsiane; h; 2 | Wong, Tien Yina; b; c; 2
Affiliations: [a] Singapore Eye Research Institute, Singapore National Eye Centre, Singapore | [b] Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore | [c] Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore | [d] NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore | [e] Memory Aging and Cognition Centre, National University Health System, Singapore | [f] Department of Geriatric Medicine, Khoo Teck Puat Hospital, Singapore | [g] Department of Geriatric Medicine, Singapore General Hospital, Singapore | [h] Department of Pharmacology, National University of Singapore, Singapore
Correspondence: [*] Correspondence to: Dr. Carol Y. Cheung, Singapore Eye Research Institute, The Academia, 20 College Road, Discovery Tower Level 6, Singapore 169856. Tel.: +65 6576 7233; E-mail: [email protected].
Note: [1] These authors contributed equally to this work as first authors.
Note: [2] These authors contributed equally to the work as last authors.
Abstract: Background:Alzheimer’s disease (AD) is a neurodegenerative disorder with emerging evidence that it is associated with retinal ganglion cell loss; however, few data exist to establish this association. Objective:To determine whether macular ganglion cell-inner plexiform layer (GC-IPL) and retinal nerve fiber layer (RNFL), as quantitatively measured by non-invasive in vivo spectral-domain optical coherence tomography (SD-OCT), are altered in patients with AD and mild cognitive impairment (MCI). Methods:Patients with AD and MCI were recruited from dementia/memory clinics, and cognitively normal controls were selected from the Singapore Epidemiology of Eye Disease program. SD-OCT (Cirrus HD-OCT, software version 6.0.2, Carl Zeiss Meditec Inc, Dublin, CA) was used to measure the GC-IPL and RNFL thicknesses. Results:Compared with cognitively normal controls (n = 123), patients with AD (n = 100) had significantly reduced GC-IPL thicknesses in all six (superior, superonasal, inferonasal, inferior, inferotemporal, and superotemporal) sectors (mean differences from –3.42 to –4.99 µm, all p < 0.05) and reduced RNFL thickness in superior quadrant (–6.04 µm, p = 0.039). Patients with MCI (n = 41) also had significantly reduced GC-IPL thicknesses compared with controls (mean differences from –3.62 to –5.83 µm, all p < 0.05). Area under receiver operating characteristic curves of GC-IPL were generally higher than that of RNFL to discriminate AD and MCI from the controls. Conclusions:Our data strengthens the link between retinal ganglion cell neuronal and optic nerve axonal loss with AD, and suggest that assessment of macular GC-IPL can be a test to detect neuronal injury in early AD and MCI.
Keywords: Alzheimer's disease, mild cognitive impairment, neurodegenerative disorder, optic nerve, retinal ganglion cell, spectral-domain optical coherence tomography
DOI: 10.3233/JAD-141659
Journal: Journal of Alzheimer's Disease, vol. 45, no. 1, pp. 45-56, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]